NovoCare self-pay program Novo Nordisk's NovoCare program offers a self-pay price of approximately $199 per month for the starting doses (0.25/0.5 mg, first two fills through December 31, 2026), then approximately $349 per month for standard injection doses
--- I'll be posting a Drug of the Week every Saturday breaking down one drug at a time, simply and clearly
Saxenda is typically prescribed for individuals with a body mass index (BMI) of: - 30 or higher (classified as obese), or - 27 or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or high cholesterol
The biggest concern around the safety of microdosing is if patients are doing it without the knowledge of their treating team (such as their GP, dietitian, and pharmacist)
Enrica Bianchi, University of York, United Kingdom Updates Copyright 2023 Nixon, Schjenken, Burke, Skerrett-Byrne, Hart, De Iuliis, Martin, Lord and Bromfield
Carek PJ, Laibstain SE, Carek SM